A non-interventional study to investigate the current situation of Asthma-COPD Overlap Syndrome in patients over age 40 with persistent airflow limitation in China

Trial Identifier: D2287R00102
Sponsor: AstraZeneca
NCTID:: NCT02600221
Start Date: October 2015
Primary Completion Date: October 2016
Study Completion Date: October 2016
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
China, Beijing Beijing, China
China, Chongqing Chongqing, China
China, Guangdong Guangzhou, Guangdong, China
China, Hainan Haikou, Hainan, China
China, Henan Zhengzhou, Henan, China
China, Hunan Changsha, Hunan, China
China, Inner Mongolia Hohhot, Inner Mongolia, China
China, Liaoning Shenyang, Liaoning, China
China, Shanghai Shanghai, China
China, Shanxi Xi'an, Shanxi, China
China, Sichuan Chengdou, Sichuan, China
China, Tianjin Tianjin, China
China, Zhejiang Hangzhou, Zhejiang, China